The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes
Open accessAbstract
Background: In pharmacotherapy, the achievement of a target clinical outcome requires a certain level of medication intake or adherence. Based on Haynes’s early empirical definition of sufficient adherence to antihypertensive medications as taking ≥80% of medication, many researchers used this threshold to distinguish adherent from non-adherent patients. However, we propose that different diseases, medications and patient’s characteristics influence the threshold of the adherence rate above which the clinical outcome is satisfactory. Moreover, the assessment of adherence and clinical outcomes may differ greatly and should be taken into consideration. We aimed at investigating medication adherence thresholds in relation to clinical outcomes. Method: We searched for studies that determined the relationship between adherence rates and clinical outcomes in the databases PubMed, Embase® and Web of Science™ until December 2017, limited to English-language. Our outcome measure was any threshold value of adherence. Inclusion criteria were 1) any measurement of medication adherence; 2) any assessment of clinical outcomes 3) any method to define medication adherence thresholds in relation to clinical outcomes. Two authors independently screened titles and abstracts for relevance, reviewed full-texts, and extracted items. The results of the included studies are presented qualitatively. Result: We analyzed six articles that assessed clinical outcomes linked to adherence rates in seven chronic disease states. Medication adherence was measured with Medication Possession Ratio (MPR, n = 3), Proportion of Days Covered (PDC, n = 1), both (n = 1), or Medication Event Monitoring System (MEMS). Clinical outcomes were event free episodes, hospitalization, cortisone use, reported symptoms and reduction of lipid levels. To find the relationship between the targeted clinical outcome and adherence rates, three studies applied logistic regression and three used survival analysis. Five studies defined adherence thresholds between 46% and 92%. One study confirmed the 80% threshold as valid to distinguish adherent from non-adherent patients. Conclusion: The analyzed studies were highly heterogeneous, predominantly concerning methods of calculating adherence. We could not compare studies quantitatively, mostly because adherence rates could not be standardized. Therefore, we cannot reject or confirm the validity of the historical 80% threshold. Nevertheless, the 80% threshold was clearly questioned as a general standard.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · cited 1×
“, adherence rate) and varies from 0% to over 100% in literature (DiMatteo, 2004; Briesacher et al., 2008; Fischer et al., 2010; Nieuwlaat et al., 2014; Huurne et al., 2015).”
BackgroundSelf-citationAdherence to Long‐Term Therapies: Evidence for Action
Burkhart, P. V., & Sabaté, E. (2003) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2003.tb00001.x · Cited by 2,526
Dichotomizing continuous predictors in multiple regression: a bad idea
Royston, P., Altman, D. G., & Sauerbrei, W. (2006) · Statistics in Medicine · doi:10.1002/sim.2331 · Cited by 2,312
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“…patient’s adherence is usually reported as percentage of the actual medication taken over a defined period of time (i.e., adherence rate) and varies from 0% to over 100% in literature (DiMatteo, 2004; Briesacher et al., 2008; Fischer et al., 2010; Nieuwlaat et al., 2014; Huurne et al., 2015).”
BackgroundA new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Medication adherence measures: An overview
Lam, W. Y., & Fresco, P. (2015) · BioMed Research International · doi:10.1155/2015/217047 · Cited by 1,308
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
An application of changepoint methods in studying the effect of age on survival in breast cancer
Contal, C., & O'Quigley, J. (1999) · Computational Statistics & Data Analysis · doi:10.1016/s0167-9473(98)00096-6 · Cited by 587
Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
Fischer, M. A., Stedman, M. R., Lii, J., Vogeli, C., Shrank, W. H., Brookhart, M. A., & Weissman, J. S. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1253-9 · Cited by 572
Can simple clinical measurements detect patient noncompliance?
Haynes, R. B., Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D., & Mukherjee, J. (1980) · Hypertension · doi:10.1161/01.hyp.2.6.757 · Cited by 514
Self-citationResistant hypertension? Assessment of adherence by toxicological urine analysis
Jung, O., Gechter, J. L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., & Toennes, S. W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835e2286 · Cited by 474
The impact of compliance with osteoporosis therapy on fracture rates in actual practice
Caro, J. J., Ishak, K. J., Huybrechts, K. F., Raggio, G., & Naujoks, C. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1652-z · Cited by 468
Breaking up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data
Streiner, D. L. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700307 · Cited by 433
Cheung, B. M. Y., Lauder, I. J., Lau, C., & Kumana, C. R. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02060.x · Cited by 304
Medication Adherence to Multidrug Regimens
Marcum, Z. A., & Gellad, W. F. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.008 · Cited by 264
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226
Maggiolo, F., Airoldi, M., Kleinloog, H. D., Callegaro, A., Ravasio, V., Arici, C., Bombana, E., & Suter, F. (2007) · HIV Clinical Trials · doi:10.1310/hct0805-282 · Cited by 157
Defining an evidence-based cutpoint for medication adherence in heart failure
Wu, J. R., Moser, D. K., Jong, M. J. D., Rayens, M. K., Chung, M. L., Riegel, B. J., & Lennie, T. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.10.001 · Cited by 150
Yang, Q., Chang, A., Ritchey, M. D., & Loustalot, F. V. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006056 · Cited by 136
Kozma, C. M., Dickson, Phillips, & Meletiche (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s40736 · Cited by 129
The myths of medication adherence
Gellad, W. F., Thorpe, C. T., Steiner, J. F., & Voils, C. I. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4334 · Cited by 98
Proposal of Standardization to Assess Adherence With Medication Records
Arnet, I., Kooij, M. J., Messerli, M., Hersberger, K. E., Heerdink, E. R., & Bouvy, M. L. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016634106 · Cited by 89
Self-citationAn upper and lower bound of the Medication Possession Ratio
Sperber, C., Samarasinghe, S. R., & Lomax, G. P. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s136890 · Cited by 87
Using Machine Learning to Examine Medication Adherence Thresholds and Risk of Hospitalization
Lo‐Ciganic, W., Donohue, J. M., Thorpe, J. M., Perera, S., Thorpe, C. T., Marcum, Z. A., & Gellad, W. F. (2015) · Medical Care · doi:10.1097/mlr.0000000000000394 · Cited by 79
Hansen, R. A., Farley, J. F., Droege, M., & Maciejewski, M. L. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.011 · Cited by 68
Revisiting the medication possession ratio threshold for adherence in lipid management
Watanabe, J. H., Bounthavong, M., & Chen, T. F. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.766164 · Cited by 53
Oleen-Burkey, M. A., Dor, A., Castelli‐Haley, J., & Lage, M. J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.618517 · Cited by 39
Doró, P., Benkő, R., Kosik, E., Matúz, M., Tóth, K., & Soós, G. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0031-9 · Cited by 37
The Adherence Rate Threshold is Drug Specific
Stauffer, M. E., Hutson, P. R., Kaufman, A. S., & Morrison, A. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0216-6 · Cited by 27
Patient-important outcomes in systematic reviews: Poor quality of evidence
Yordanov, Y., Dechartres, A., & Ravaud, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195460 · Cited by 26
Differences in Adherence to Common Inhaled Medications in COPD
Huurne, K. K.-T., Movig, K. L. L., van der Valk, P., van der Palen, J. A. M., & Brusse-Keizer, M. G. J. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.995292 · Cited by 25
Cited by
Pedrosa-Naudín, M. A., Gutiérrez-Abejón, E., Herrera-Gómez, F., Fernández-Lázaro, D., & Álvarez, F. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122696 · Cited by 31
Qin, X., Hung, J., Knuiman, M. W., Briffa, T. G., Teng, T.-H. K., & Sanfilippo, F. M. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03467-7 · Cited by 12
Othman, N. O., Abdel-Aal, H. H., Elsherief, W. A., Farag, D. E., Hunter, C. N., & Alsirafy, S. A. (2025) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2025.7033 · Cited by 11
Dong, X., Tsang, C. C. S., Wan, J. Y., Chisholm-Burns, M. A., Finch, C. K., Tsao, J. W., Browning, J. A., Garuccio, J., Zeng, R., & Wang, J. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100420 · Cited by 1
Metadata
- Authors
- Baumgartner, P. C., Haynes, R. B., Hersberger, K. E., & Arnet, I.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-20
- Volume
- 9
- Pages
- 1290-1290
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2901418399
- Cited by
- 255
- References
- 37
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.